Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AHROQ registration revoked:
https://www.sec.gov/litigation/opinions/2021/34-92890.pdf
AHROQ SEC Suspension for severely delinquent Financials:
https://www.sec.gov/litigation/suspensions/2021/34-91946.pdf
Order:
https://www.sec.gov/litigation/suspensions/2021/34-91946-o.pdf
Admin. Proceeding:
https://www.sec.gov/litigation/admin/2021/34-91945.pdf
$AHROQ: Told you it was gonna continue to DROP
Already hit $0.0079
$AHROQ
$AHROQ: Bidding $0.0045 on it.........
Need more info on it to be convinced on upside.
$AHROQ
Today's pick is: AHROQ
Let’s get right to it…
My HUGE New Power Packed Day Trade Alert Is: AHROQ
Wall Street is about to Show Major Interest in AHROQ!
Symbol: AHROQ
Co Name: AtheroNova Inc.
Breakout Catalyst: (+)
AHROQ Is On Immediate ALERT!
About AtheroNova Inc.
AtheroNova Inc. is a clinical stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. Atherosclerotic plaque, which progressively narrows and blocks arteries, is the main underlying pathology of cardiovascular disease and the leading killer in industrialized nations worldwide. The Company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion dollar prescription drug market: cardiovascular disease and stroke prevention.
I am issuing an immediate alert on AHROQ.
As I have mentioned before, a 'low float + high demand = explosion in share price!'
A huge increase in demand during today’s trading session could send AHROQ skyrocketing up the charts.
The trading session has already begun, so don't delay and pull up AHROQ on your trading screen before you miss out on another easy profitable day trading idea scenario!
Yours for greater profits,
GhosT
insane pump you guys had going here.
CDVIQ has almost no volume lol...
The easiest, pretty much a garbage site, but lists p and D's, is THEOTC.TODAY.
Can you send me the sites you used to notify you of this pump and why to buy today? Would of loved to been there at the open with you this AM!
That's hard to say, depends on your broker among other things. But, these P and Ds usually stack the bid pretty good because they know where it is going. But, pretty unlikely. I placed .015 at the open and only got a partial fill, sold into the bid shortly thereafter. It's manipulation at it's finest.
if i put in a purchase of 250,000 shares at .0095 at 930, would it have been executed?
I got lucky, filled most of my bid within a few minutes after open, dumped under the ask shortly thereafter...could go higher, but, happy to be out, would like all my trades to last 7 minutes or less and return a big %...truthfully, didn't expect to get filled on the bid...
$AHROQ: Interesting Q play here... $CDVIQ is better
$20Million clawback trial still pending.
$CDVIQ
I never jumped in... saw at .009 then .05! Pssshhh not my first day playing the stinky Pinks!
Absolutely, quick hit, then, run for the hills, multi site pump, good window of ownership is about 18 minutes IMO...all out, no need to look back.
Fantastic news! > Run away > huge upside!
Pump and dump today! Get in and out quick!
To expensive yet, wait for a forward spilt and the stock to hit par then roll the dice.
NOT a good thing at all:
AHROQ .015 x .025 bankruptcy case dismissed:
http://www.turnaroundletter.com/blogs/15-bankruptcy-news/post/30407-atheronova-case-dismissed
NOTICE OF HEARING ON DISCLOSURE STATEMENT DESCRIBING DEBTORS' (PLAN OF REORGANIZATION (DATED JUNE 22, 2015)
AtherNova Operations, Inc. and AtheroNova Inc. (Jointly administered) will have a hearing in the US Bankruptcy Court, Central District of California, Santa Ana Division.
Disclosure Statement Hearing:
Date: July 28, 2015
Time: 10:30 a.m.
Place: Courtroom 5A
411 West Fourth Street
Santa Ana, California
Above information was gleaned from a notice by the Attorneys for Chapter 11 Debtors and Debtors in Possession
AtheroNova has filed for Chapter 11, and while they are in this process, waiting for direction from the court, business continues as usual. Keep in mind the company had to have a plan in hand before filing Chapter 11. It is a re-structuring process.
Hopefully the news will be good by the end of the second quarter for Phase 1b, and the final top line wording from Phase I.
You may like to read about the Chapter 11 procedure:
http://bankruptcy.findlaw.com/chapter-13/chapter-11-bankruptcy.html
I'm trying to figure out, if AHROQ was sold, just how much the patents are worth? There's a few companies out there with Subcutaneous Fat Reduction (Their 3rd patent) patents but differ from the one ARHOQ has.
Unfortunately, Subs is right around the corner for this company.
Been following. Don't own.
Hey, smitty !!!
You watching this baby too ???
I just came aboard.
another nice *POP* 2day on very few shares
AHRO changed to AHROQ: bankruptcy:
http://otce.finra.org/DLSymbolNameChanges
Funny. A penny stock ($0.05) filed bankruptcy. So, going to sub-penny ? !
Nice job. I tried to do the same, but thought it would go lower than .012.
well at least sumbody bought 57k @ .0121 and sold them @ .025
Chapter 11 bankrupcy is different than standard bankrupcy
Named after the U.S. bankruptcy code 11, Chapter 11 is a form of bankruptcy that involves a reorganization of a debtor's business affairs and assets. It is generally filed by corporations which require time to restructure their debts.
Chapter 11 gives the debtor a fresh start, subject to the debtor's fulfillment of its obligations under its plan of reorganization.
This does not look good for the company but it doesn't mean they will fold. It did state in the release that their trial is complete and hopefully will come out with the data soon as this will be a leverage to assess value to the company.
Yeah, nice job holding off.
Thanks God I didn't buy I was very close to pull the trigger couple of times
Thank God I sold again yesterday.
AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection PR Newswire "Press Releases US - English"
IRVINE, Calif. , March 3, 2015 /PRNewswire/ -- AtheroNova Inc. (OTCQB: AHRO) today announced that the Company and its subsidiary, AtheroNova Operations, Inc. , filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court, Central District of California , Santa Ana division (the " Bankruptcy Court ") on March 2, 2015 . The Company's Chapter 11 cases are expected to be jointly administered.
The Company will evaluate all options, including a Bankruptcy Court supervised asset sale process, for all or substantially all of its assets to a party who could potentially be interested in continuing the Company's clinical programs.
During the bankruptcy process, the Company will continue to operate in the ordinary course, including continuing the evaluation of its recently concluded Phase 1b clinical trial in Russia . In addition, the Company intends to request Bankruptcy Court approval of a series of customary motions. Bankruptcy Court documents and additional information are available as indicated below.
Levene, Neale, Bender, Yoo & Brill L.L.P. is serving as the Company's bankruptcy counsel, and Sherwood Partners, LLC is serving as the Company's financial advisor and sales agent in this process.
try zero--just filed Bankruptcy
If the person who is trying to buy 60K is on here, please PM me. TIA
Bought another starter at .06 again. GLTA
It was! Made a nice profit it on it. You jumping in here?
nice starter! @ .056
They have $1 million cash to pay more than $4.2 million in accelerated debt. If they use all their cash and issue the rest in shares, that would be more than 40 million shares on a current float of 4 million shares.
They are doomed.
I'm not saying this is a recent thing. Weiner and Knoll have been involved with AHRO since at least 2010. Plenty of pumping happened since. They closed the 2.5% notes just days before the stock skyrocketed.
Their whole scheme is slowly crumbling and now they are trying to get out of AHRO.
This is no where near a pump and dump.
Look at their news, NONE. They have not been pumping anything. If you think its a pump and dump and the Fred Knoll is involved, why would he want the stock to tank if he owns a ton of shares? So he can sell them for nothing? Doesn't make sense. I do know that they need some news soon otherwise this is trouble. I'm still holding given its a horrible time to sell after the stock takes a dive. I'm hoping they look to sell the company which would still bring a decent amount as their debt is not bad for a company this size.
You can forget about survival. This thing will get shutdown soon. AHRO is just another pump and dump vehicle for David Weiner and Fred Knoll.
These guys are behind W-Net and Europa International, the 2 companies who holds a ton of notes from AHRO. They are the same guys behind PHOT, SLNN and other stocks victim of pump and dump.
If you want to know more about them, here's an article scratching the surface of how these guys operate: http://www.bloomberg.com/news/articles/2014-06-18/legal-pot-sets-off-penny-stock-frenzy
I agree that the Top Line test results for Ph.1 and 1b are needed quickly if survival is in the cards.
We need positive trial results like yesterday for AHRO-001. Its an outside chance of getting funding based on good results but the clock is ticking.
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
334
|
Created
|
12/05/09
|
Type
|
Free
|
Moderators |
AtheroNova is an early stage biotech company focused on the discovery, research, development and licensing of novel compounds designed to reduce or eliminate atherosclerotic plaque deposits. AtheroNova has developed intellectual property for a class of compounds that have the potential to significantly reduce the incidence and severity of atherosclerosis.
Existing classes of cholesterol reduction drugs, including statins, have demonstrated market success, rapidly achieving blockbuster status and billions of dollars in sales without demonstrating any efficacy at reducing atherosclerosis at commonly used dosage levels. Only one study demonstrated even minimal efficacy at reducing plaque, and then only on patients taking the maximum approved dosage for two years.
Although additional research and development is required, AtheroNova has the potential to produce atherosclerosis drugs that will regress or eliminate atherosclerotic fatty plaques. The Company is currently completing two additional studies to validate the efficacy findings of its initial study and prepare for upcoming human trials. The Company plans to develop multiple applications for its compounds.
Market Value1 | $30,529,182 | a/o Nov 16, 2011 |
Shares Outstanding | 27,753,802 | a/o Oct 27, 2011 |
Float | Not Available | |
Authorized Shares | 100,000,000 | a/o Jun 30, 2011 |
Par Value | 0.001 |
Shareholders of Record | 70 | a/o Mar 31, 2011 |
|
Short Interest | 0 (-100%) Oct 31, 2011 |
Significant Failures to Deliver | No |
Securities Transfer Corp. |
Details |
---|
|
AtheroNova Inc. is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. Atherosclerotic plaque, which progressively narrows and blocks arteries, is the main underlying pathology of cardiovascular disease and the leading killer in industrialized nations worldwide. The Company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion dollar prescription drug market: cardiovascular disease and stroke prevention.
Key Investment Considerations
$41+ Billion market potential
Strong IP protection
Identifiable milestones
Potentially lower risk of safety or efficacy problems than is typical in drug development
Strong management team with successful track record
Capital structure
Medium Term Indicators Average: 25% Buy | |||||||||||
50-Day Average Volume - 6,468 | |||||||||||
Long Term Indicators | |||||||||||
60 Day Commodity Channel Index | Hold | ||||||||||
100 Day Moving Average vs Price | Buy | ||||||||||
50 - 100 Day MACD Oscillator | Buy | ||||||||||
Long Term Indicators Average: 67% Buy | |||||||||||
100-Day Average Volume - 9,595 | |||||||||||
Overall Average: 8% Buy | |||||||||||
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |